QUANTUM - DRIVEN THERANOSTICS PLATFORM
QUANTALPHA
THERANOSTICS
Building the Quantum Future of Theranostics
VISION & MISSION
The quantalpha Foundation supports a new era of cancer care
Recognizing a paradigm shift in cancer care to a personalized approach, the QUANTALPHA Foundation´s vision is to scale global patient access to Radiomolecular Precision Oncology – also known as Theranostics – building a future where all patients in need can benefit from this innovative, highly targeted therapy with low side effects, improved efficacy and better patient outcomes.
THE QUANTALPHA FOUNDATION SUPPORTS A NEW ERA OF CANCER CARE ...
Together with partners worldwide, the QUANTALPHA Foundation is on a mission to establish an international network of certified QUANTALPHA Centers of Excellence by sharing knowledge and standards in Theranostics. Aiming at sustainable patient access growth at each center, the QUANTALPHA Foundation has developed the QUANTALPHA Academy for Theranostics, a world-class online education platform dedicated to healthcare professionals active in Theranostics. Moreover, the QUANTALPHA Foundation supports young talents via research grants and nurtures a strong collaborative community, also by organizing its own virtual and in-person Events– advancing the field of Theranostics and listening to the patient voice.
With the aspiration of reaching 1 million patients treated worldwide with high standards of care, ICPO has developed a unique strategy that takes into account regional and national realities and the different maturity levels of Theranostics centers. This approach is reinforced through strong partnerships with leading medical societies and scientific experts, non-profits, patient associations, governmental institutions and industry players.
Engaged in four key activities, QUANTALPHA is building a future where all patients in need can be treated with Theranostics – an innovative and personalized approach to cancer care.
Your QUANTALPHA Team

James Jerry
Sen. h.c. Udo J. Vetter Chairman of the Board of Trustees

Serin Jerry
Odile Jaume CEO
QUANTALPHA´S FOUR KEY ACTIVITIES
Join the worldwide network of ICPO Clinical Theranostics Centers of Excellence and get your center accredited! Through standardized processes, shared expertise, and certified education, ICPO will support your center to improve cancer patient outcomes and contribute locally to a global mission.
